Get the Stockscreener App
19.49
0.05%
-0.01
After Hours:
18.86
-0.63
-3.23%
Progyny Inc stock is traded at $19.49, with a volume of 840.48K.
It is down -0.05% in the last 24 hours and down -10.11% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$19.50
Open:
$19.66
24h Volume:
840.48K
Relative Volume:
0.65
Market Cap:
$1.68B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
30.94
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
+0.78%
1M Performance:
-10.11%
6M Performance:
-14.89%
1Y Performance:
+25.34%
1-Day Range:
$19.27
$19.66
1-Week Range:
$18.85
$19.95
52-Week Range:
$13.39
$26.76
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
19.49 | 1.68B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
362.50 | 326.45B | 422.82B | 22.09B | 25.27B | 23.09 |
|
CVS
Cvs Health Corp
|
81.93 | 102.82B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
CI
Cigna Group
|
301.78 | 81.43B | 261.22B | 5.40B | 3.94B | 18.31 |
|
ELV
Elevance Health Inc
|
342.35 | 76.96B | 194.82B | 5.53B | 3.77B | 24.45 |
|
HUM
Humana Inc
|
290.65 | 35.04B | 123.11B | 1.58B | 2.44B | 13.03 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
How high can Progyny Inc. stock goMarket Weekly Review & Long-Term Safe Investment Plans - newser.com
How hedge fund analytics apply to Progyny Inc. stockWeekly Trading Summary & Weekly High Potential Stock Alerts - newser.com
What analyst consensus says on Progyny Inc. stockTrade Volume Report & Real-Time Chart Breakout Alerts - newser.com
Progyny Inc. recovery potential after sell off2025 Earnings Impact & Fast Moving Trade Plans - newser.com
Visual analytics tools that track Progyny Inc. performanceMarket Performance Report & Daily Stock Momentum Reports - newser.com
Progyny Inc Stock Analysis and ForecastIndustrial Stocks Review & Fast Growing Capital Gains - earlytimes.in
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report - The Manila Times
Progyny, Inc. to Announce Q3 2025 Financial Results and Host Conference Call on November 6, 2025 - Quiver Quantitative
Progyny (NASDAQ: PGNY) sets Nov. 6 results call for 4:45 p.m. ET; third-quarter results - Stock Titan
Are Investors Undervaluing Progyny (PGNY) Right Now? - Yahoo Finance
Progyny to launch global pregnancy, postpartum and menopause programs By Investing.com - Investing.com Australia
Applying chart zones and confluence areas to Progyny Inc.Bull Run & AI Based Buy and Sell Signals - newser.com
Will Progyny's (PGNY) Global Women’s Health Push Redefine Its Competitive Edge? - Yahoo
Progyny, Inc. (PGNY) Stock forecasts - Yahoo
Progyny, Inc. (PGNY) Stock Forecasts - Yahoo Finance
Progyny to launch global pregnancy, postpartum and menopause programs - Investing.com
Progyny (PGNY) Expands Services with New Pregnancy and Menopause Programs - GuruFocus
Progyny, Inc. Launches Comprehensive Pregnancy, Postpartum, and Menopause Programs for Global Employers Starting January 2026 - Quiver Quantitative
Progyny (NASDAQ: PGNY) debuts pregnancy, postpartum, menopause support in 127+ countries - Stock Titan
Using Ichimoku Cloud for Progyny Inc. technicals2025 Sector Review & Low Risk High Win Rate Picks - newser.com
Is Progyny Inc. stock ready for a breakoutJuly 2025 Action & Community Consensus Stock Picks - newser.com
Transcarent Experience Store Expansion: More Options for Women’s Health - Nasdaq
Canaccord Genuity Reaffirms Their Hold Rating on Progyny (PGNY) - The Globe and Mail
Progyny, Inc. (PGNY) Stock Analysis: Exploring a 43.91% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Is a relief rally coming for Progyny Inc. holders2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Progyny gains as White House reportedly eyeing proposal to make IVF more accessible - MSN
Will breakout in Progyny Inc. lead to full recoveryBull Run & Fast Exit/Entry Strategy Plans - newser.com
Is Progyny Inc. stock ready for breakoutTrade Ideas & Weekly Market Pulse Updates - nchmf.gov.vn
Will Progyny Inc. stock gain from strong economyJuly 2025 Short Interest & Safe Entry Momentum Tips - nchmf.gov.vn
Is Progyny Inc. stock safe for conservative investorsInflation Watch & Free Real-Time Market Sentiment Alerts - nchmf.gov.vn
Trade Recap: Can Progyny Inc. stock sustain institutional interestMarket Sentiment Summary & Weekly Return Optimization Plans - nchmf.gov.vn
Progyny (PGNY) Shares Swing Amid New Fertility Initiative - GuruFocus
Shorts Report: Can Progyny Inc. stock sustain institutional interestWeekly Profit Summary & Weekly Return Optimization Plans - Trung tâm Dự báo KTTV quốc gia
Progyny seesaws amid confusion over impact from Trump’s IVF initiative - MSN
Market reaction to Progyny Inc.’s recent newsQuarterly Performance Summary & Weekly Watchlist for Consistent Profits - newser.com
Progyny Stock Logs Best Day In 2 Months As BofA Calls Trump IVF Policy ‘Incremental Positive’ — Traders Eye More Upside - Stocktwits
Progyny (PGNY) Maintains Buy Rating Amid IVF Policy Buzz - GuruFocus
Progyny (PGNY) Shares Rise on White House IVF Coverage Plans - GuruFocus
Progyny (PGNY) Shares Rise on Proposed IVF Access Expansion - GuruFocus
Progyny climbs after report of White House IVF proposal - TradingView
Progyny (PGNY): Exploring Valuation After Recent Momentum Shift and Investor Optimism - Yahoo Finance
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.27%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):